Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Featured
Off
Key highlights
- Ten ATTR patients (mean age 63.8 years) received inotersen or patisiran at University Health Network.
- 90% showed cardiac improvement on PYP scans; 1 patient worsened.
- Serial PYP scintigraphy may provide an objective tool to monitor treatment response in ATTR.
Source
Arivalagan P, Delgado DH. Comparative study on cardiac findings in patients with transthyretin amyloidosis before and after treatment with a transthyretin silencer. J Cardiovasc Dev Dis. 2025;12(9):342. doi:10.3390/jcdd12090342
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
Retrospective analysis finds improvements in PYP scan results and cardiac function in amyloidosis patients treated with inotersen or patisiran.
User Segments
Release Date
Featured Order
0
Is Paid
0